-+ 0.00%
-+ 0.00%
-+ 0.00%

BMO Capital Maintains Outperform on Ingevity, Raises Price Target to $68

Benzinga·09/05/2025 15:38:53
Listen to the news
BMO Capital analyst John McNulty maintains Ingevity (NYSE:NGVT) with a Outperform and raises the price target from $62 to $68.